Table 1 Demographic and baseline characteristics of the participants.
Feature | BBIBP-CorV | PastoCovac Plus | PastoCovac | P-value |
|---|---|---|---|---|
Population | (n = 74) | (n = 72) | (n = 68) | |
Female | 37 (50.0%) | 35 (48.6%) | 34 (50.0%) | 0.982b |
Male | 37 (50.0%) | 37 (51.4%) | 34 (50.0%) | |
Age | ||||
Mean (SD) | 43.0* (14.6) | 41.9 (12.8) | 41.3 (13.8) | 0.775a |
≤ 50 | 49 (66.2%) | 53 (73.6%) | 48 (70.6%) | 0.618b |
> 50 | 25 (33.8%) | 19 (26.4%) | 20 (29.4%) | |
COVID history | ||||
No | 60 (81.1%) | 63 (87.5%) | 55 (80.9%) | 0.484b |
Yes | 14 (18.9%) | 9 (12.5%) | 13 (19.1%) | |
Underlying disease | ||||
No | 62 (83.8%) | 65 (90.3%) | 62 (91.2%) | 0.320b |
Yes | 12 (16.2%) | 7 (9.7%) | 6 (8.8%) | |
